| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $796.9M | +0.6% |
| R&D Expense | $121.0M | -2.2% |
| SG&A Expense | $114.0M | -3.3% |
| Operating Income | $87.5M | +32.9% |
| Pre-tax Income | $56.5M | +79.7% |
| Income Tax | $26.1M | +73.2% |
| Net Income | $30.4M | +85.7% |
| EPS (Basic) | $0.09 | +125.0% |
| EPS (Diluted) | $0.09 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $261.8M | -41.6% |
| Accounts Receivable | $235.7M | +61.5% |
| Current Assets | $643.1M | -2.5% |
| Total Assets | $1.40B | +1.2% |
| Current Liabilities | $246.0M | +98.5% |
| Long-term Debt | $495.0M | -1.0% |
| Total Liabilities | $787.8M | +18.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $167.9M | -8.7% |
| Capital Expenditures | $3.5M | +184.0% |
| Investing Cash Flow | -$120.0M | -70.5% |
| Financing Cash Flow | -$234.5M | +30.5% |
| Free Cash Flow | $164.4M | -10.0% |
| +125.0% |
| Stockholders' Equity |
| $616.3M |
| -15.0% |